|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-7-13
|
|
pubmed:abstractText |
p27(Kip1) (p27), a cyclin-dependent kinase inhibitor, has an important role in the progression of cells from G(1) into S phase of the cell cycle. p27 may act as a tumor suppressor, and several reports suggest that loss of its expression in breast carcinoma is related to tumor progression and poor prognosis. We evaluated p27 immunohistochemical expression in 512 consecutive cases of breast carcinoma with 9 years of median-term follow-up. p27 expression was heterogeneous and frequently less intense than in normal cells. Low p27 expression (<50% of reacting cells) was associated with grade III tumors, N0 status, estrogen receptor-negative status, and low cyclin D1 expression. In the whole series of cases, p27 expression did not predict outcome. In node-negative cases (249 patients), high p27 expression indicated poor prognosis. p27 was not prognostically relevant in the group of 223 patients with pT1 disease or in the group of 154 patients <50 years of age. We also investigated the prognostic value of the combined expression of p27 and cyclin D1, but no differences in survival were seen in this bivariate analysis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0020-7136
|
|
pubmed:author |
pubmed-author:BarbareschiMM,
pubmed-author:CaffoOO,
pubmed-author:Dalla PalmaPP,
pubmed-author:DoglioniCC,
pubmed-author:GalligioniEE,
pubmed-author:MaisonneuvePP,
pubmed-author:MauriF AFA,
pubmed-author:MichalidesRR,
pubmed-author:PeterseHH,
pubmed-author:ScaioliMM,
pubmed-author:VeroneseSS,
pubmed-author:van TinterenHH
|
|
pubmed:copyrightInfo |
Copyright 2000 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
20
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
236-41
|
|
pubmed:dateRevised |
2007-7-24
|
|
pubmed:meshHeading |
pubmed-meshheading:10861499-Adult,
pubmed-meshheading:10861499-Aged,
pubmed-meshheading:10861499-Breast Neoplasms,
pubmed-meshheading:10861499-Carcinoma, Ductal, Breast,
pubmed-meshheading:10861499-Cell Cycle Proteins,
pubmed-meshheading:10861499-Cyclin-Dependent Kinase Inhibitor p27,
pubmed-meshheading:10861499-Disease-Free Survival,
pubmed-meshheading:10861499-Female,
pubmed-meshheading:10861499-Follow-Up Studies,
pubmed-meshheading:10861499-Humans,
pubmed-meshheading:10861499-Immunohistochemistry,
pubmed-meshheading:10861499-Lymphatic Metastasis,
pubmed-meshheading:10861499-Menopause,
pubmed-meshheading:10861499-Microtubule-Associated Proteins,
pubmed-meshheading:10861499-Middle Aged,
pubmed-meshheading:10861499-Recurrence,
pubmed-meshheading:10861499-Time Factors,
pubmed-meshheading:10861499-Tumor Suppressor Proteins
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up.
|
|
pubmed:affiliation |
Department of Histopathology, St. Chiara Hospital, Trento, Italy. barbareschi@tn.aziendasanitaria.trentino.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
